Aklillu, Eleni
Karolinska University Hospital · Karolinska Institutet
4 papers on CoChatORCID 0000-0002-9788-0790
Most cited papers
- Verified
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2
McDonagh, E. M., Boukouvala, S., Aklillu, E., Hein, D. W., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics
Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology
Cited by 146
- Verified
Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
Mikomangwa, W. P., Minzi, O., Mutagonda, R., Baraka, V., Mlugu, E. M., Aklillu, E., & Kamuhabwa, A. A. R. (2020) · Malaria Journal
Malaria Research and ControlGlobal Maternal and Child Health
Cited by 36
- Verified
N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians
Aklillu, E., Carrillo, J. A., Makonnen, E., Bertilsson, L., & Djordjevic, N. (2018) · European Journal of Clinical Pharmacology
Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology
Cited by 28
- Verified
Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women
Mlugu, E. M., Minzi, O., Asghar, M., Färnert, A., Kamuhabwa, A. A. R., & Aklillu, E. (2020) · Pathogens
Malaria Research and ControlGlobal Maternal and Child Health
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free